Upregulation of MTA1 expression by human papillomavirus infection promotes CDDP resistance in cervical cancer cells via modulation of NF-κB/APOBEC3B cascade
Objective Compelling evidence establishes the etiological role of viral proteins E6 and E7 of high-risk human papillomaviruses (HPV) in cervical carcinogenesis, but their contribution in chemoresistance that leads to advanced metastatic lesions remains poorly defined. Since metastasis-associated pro...
Gespeichert in:
Veröffentlicht in: | Cancer chemotherapy and pharmacology 2019-04, Vol.83 (4), p.625-637 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 637 |
---|---|
container_issue | 4 |
container_start_page | 625 |
container_title | Cancer chemotherapy and pharmacology |
container_volume | 83 |
creator | Jia, Qiu-ping Yan, Chang-you Zheng, Xue-rong Pan, Xia Cao, Xin Cao, Lei |
description | Objective
Compelling evidence establishes the etiological role of viral proteins E6 and E7 of high-risk human papillomaviruses (HPV) in cervical carcinogenesis, but their contribution in chemoresistance that leads to advanced metastatic lesions remains poorly defined. Since metastasis-associated protein 1 (MTA1) upregulation and augmentation of APOBEC3B expression are both strongly associated with cervical cancer (CCa) development, and both molecules have been shown to be functionally associated with NF-κB pathway, we therefore sought to investigate the potential mechanistic link between MTA1, APOBEC3B and NF-κB during the pathogenesis of cisplatin (CDDP) resistance in HPV-positive CCa cells.
Methods
MTA1 expression was assessed in HPV-transfected CCa cells using quantitative RT-PCR and immunoblotting. Effects of MTA1 deregulation on CDDP chemosensitivity in CCa cells were determined by measuring cell viability, apoptosis and in vivo oncogenic capacity. Finally, we studied the transcriptional regulation of the antiviral DNA cytosine deaminase APOBEC3B by MTA1 using multiple approaches including DNA deaminase activity assay, luciferase reporter assay, chromatin immunoprecipitation, co-immunoprecipitation and transient/stable transfection, at the molecular and functional levels.
Results
Expression levels of MTA1 were significantly induced in HPV-positive CCa cells. Transduction experiments showed that the E6 oncoprotein alone was sufficient to cause MTA1 upregulation. Moreover, MTA1 knockdown potentiated CDDP sensitivity in highly metastatic CCa cells. Mechanistically, MTA1 acted as an indirect upstream modulator of APOBEC3B transcription during the pathogenesis of CDDP chemoresistance. HPV-mediated stimulation of APOBEC3B expression was accompanied by the enhanced recruitment of Iκκ α/β and p65 to the NF-κB consensus sites in the
APOBEC3B
promoter, and this recruitment was substantially abrogated by MTA1 siRNA treatment.
Conclusions
These findings reveal an obligatory coregulatory role of MTA1 in the indirect regulation of APOBEC3B expression via classical NF-κB pathway, and also suggest that inhibition of MTA1/NF-κB/APOBEC3B cascade may be repositioned to suppress cancer mutagenesis, dampen tumor evolution, and decrease the probability of adverse outcomes from CDDP resistance in CCa. |
doi_str_mv | 10.1007/s00280-018-03766-2 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2165962905</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2165962905</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2902-3339dee69db9e7fd654aba18f623c8ecb0e2371ce806fd28bf8127ab5c0074443</originalsourceid><addsrcrecordid>eNp9kUtOHDEURa0oUegAG2CALGXs8Pwpl2vY3UASiQADGFsu1ysoVD_srlZYTDaSRWRNcdP8RowsP597r54vIQccvnGA_CgCCAMMuGEgc62Z-EBmXEnBwCj5kcxAKsWyHNQO-RLjHQAoLuVnsiNBS24KMyN_rseAN1PrVs3Q06Gmv67mnOLvNI1xMyof6O3UuZ6ObmzadujcuglTpE1fo38UjWHohhVGujw-vqRJ18SV6z0mhHoM68a7lvrNJKR720a6bhzthupN6vkp-_d3cTS_vFicLOUi4dG7CvfIp9q1Efefzl1yfXpytfzBzi6-_1zOz5gXBQgmpSwqRF1UZYF5XelMudJxU2shvUFfAgqZc48GdF0JU9aGi9yVmU_fqJSSu-Tr1jftcj9hXNm7YQp9irSC66zQKSZLlNhSPgwxBqztGJrOhQfLwW4asdtGbGrEPjZiRRIdPllPZYfVi-S5ggTILRDTU3-D4TX7Hdv_r1OYaA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2165962905</pqid></control><display><type>article</type><title>Upregulation of MTA1 expression by human papillomavirus infection promotes CDDP resistance in cervical cancer cells via modulation of NF-κB/APOBEC3B cascade</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Jia, Qiu-ping ; Yan, Chang-you ; Zheng, Xue-rong ; Pan, Xia ; Cao, Xin ; Cao, Lei</creator><creatorcontrib>Jia, Qiu-ping ; Yan, Chang-you ; Zheng, Xue-rong ; Pan, Xia ; Cao, Xin ; Cao, Lei</creatorcontrib><description>Objective
Compelling evidence establishes the etiological role of viral proteins E6 and E7 of high-risk human papillomaviruses (HPV) in cervical carcinogenesis, but their contribution in chemoresistance that leads to advanced metastatic lesions remains poorly defined. Since metastasis-associated protein 1 (MTA1) upregulation and augmentation of APOBEC3B expression are both strongly associated with cervical cancer (CCa) development, and both molecules have been shown to be functionally associated with NF-κB pathway, we therefore sought to investigate the potential mechanistic link between MTA1, APOBEC3B and NF-κB during the pathogenesis of cisplatin (CDDP) resistance in HPV-positive CCa cells.
Methods
MTA1 expression was assessed in HPV-transfected CCa cells using quantitative RT-PCR and immunoblotting. Effects of MTA1 deregulation on CDDP chemosensitivity in CCa cells were determined by measuring cell viability, apoptosis and in vivo oncogenic capacity. Finally, we studied the transcriptional regulation of the antiviral DNA cytosine deaminase APOBEC3B by MTA1 using multiple approaches including DNA deaminase activity assay, luciferase reporter assay, chromatin immunoprecipitation, co-immunoprecipitation and transient/stable transfection, at the molecular and functional levels.
Results
Expression levels of MTA1 were significantly induced in HPV-positive CCa cells. Transduction experiments showed that the E6 oncoprotein alone was sufficient to cause MTA1 upregulation. Moreover, MTA1 knockdown potentiated CDDP sensitivity in highly metastatic CCa cells. Mechanistically, MTA1 acted as an indirect upstream modulator of APOBEC3B transcription during the pathogenesis of CDDP chemoresistance. HPV-mediated stimulation of APOBEC3B expression was accompanied by the enhanced recruitment of Iκκ α/β and p65 to the NF-κB consensus sites in the
APOBEC3B
promoter, and this recruitment was substantially abrogated by MTA1 siRNA treatment.
Conclusions
These findings reveal an obligatory coregulatory role of MTA1 in the indirect regulation of APOBEC3B expression via classical NF-κB pathway, and also suggest that inhibition of MTA1/NF-κB/APOBEC3B cascade may be repositioned to suppress cancer mutagenesis, dampen tumor evolution, and decrease the probability of adverse outcomes from CDDP resistance in CCa.</description><identifier>ISSN: 0344-5704</identifier><identifier>EISSN: 1432-0843</identifier><identifier>DOI: 10.1007/s00280-018-03766-2</identifier><identifier>PMID: 30631898</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Animals ; Antineoplastic Agents - pharmacology ; Apoptosis ; Cancer ; Cancer Research ; Carcinogenesis ; Carcinogens ; Cervical cancer ; Cervix ; Chemoresistance ; Chemotherapy ; Chromatin ; Cisplatin ; Cisplatin - pharmacology ; Cytidine Deaminase - metabolism ; Cytosine ; Cytosine deaminase ; Deoxyribonucleic acid ; Deregulation ; DNA ; DNA-Binding Proteins - metabolism ; Etiology ; Female ; Gene regulation ; Human papillomavirus ; Humans ; Immunoblotting ; Immunoprecipitation ; In vivo methods and tests ; Lesions ; Medicine ; Medicine & Public Health ; Metastases ; Metastasis ; Mice, Inbred BALB C ; Mice, Nude ; Minor Histocompatibility Antigens - metabolism ; Mutagenesis ; NF-kappa B - metabolism ; NF-κB protein ; Oncogene Proteins, Viral - metabolism ; Oncology ; Original Article ; Papillomaviridae ; Papillomavirus Infections - complications ; Pathogenesis ; Pharmacology/Toxicology ; Polymerase chain reaction ; Proteins ; Repressor Proteins - genetics ; siRNA ; Trans-Activators - genetics ; Transcription ; Transfection ; Up-Regulation ; Uterine Cervical Neoplasms - drug therapy ; Uterine Cervical Neoplasms - virology ; Xenograft Model Antitumor Assays</subject><ispartof>Cancer chemotherapy and pharmacology, 2019-04, Vol.83 (4), p.625-637</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2019</rights><rights>Cancer Chemotherapy and Pharmacology is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2902-3339dee69db9e7fd654aba18f623c8ecb0e2371ce806fd28bf8127ab5c0074443</citedby><cites>FETCH-LOGICAL-c2902-3339dee69db9e7fd654aba18f623c8ecb0e2371ce806fd28bf8127ab5c0074443</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00280-018-03766-2$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00280-018-03766-2$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51298</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30631898$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jia, Qiu-ping</creatorcontrib><creatorcontrib>Yan, Chang-you</creatorcontrib><creatorcontrib>Zheng, Xue-rong</creatorcontrib><creatorcontrib>Pan, Xia</creatorcontrib><creatorcontrib>Cao, Xin</creatorcontrib><creatorcontrib>Cao, Lei</creatorcontrib><title>Upregulation of MTA1 expression by human papillomavirus infection promotes CDDP resistance in cervical cancer cells via modulation of NF-κB/APOBEC3B cascade</title><title>Cancer chemotherapy and pharmacology</title><addtitle>Cancer Chemother Pharmacol</addtitle><addtitle>Cancer Chemother Pharmacol</addtitle><description>Objective
Compelling evidence establishes the etiological role of viral proteins E6 and E7 of high-risk human papillomaviruses (HPV) in cervical carcinogenesis, but their contribution in chemoresistance that leads to advanced metastatic lesions remains poorly defined. Since metastasis-associated protein 1 (MTA1) upregulation and augmentation of APOBEC3B expression are both strongly associated with cervical cancer (CCa) development, and both molecules have been shown to be functionally associated with NF-κB pathway, we therefore sought to investigate the potential mechanistic link between MTA1, APOBEC3B and NF-κB during the pathogenesis of cisplatin (CDDP) resistance in HPV-positive CCa cells.
Methods
MTA1 expression was assessed in HPV-transfected CCa cells using quantitative RT-PCR and immunoblotting. Effects of MTA1 deregulation on CDDP chemosensitivity in CCa cells were determined by measuring cell viability, apoptosis and in vivo oncogenic capacity. Finally, we studied the transcriptional regulation of the antiviral DNA cytosine deaminase APOBEC3B by MTA1 using multiple approaches including DNA deaminase activity assay, luciferase reporter assay, chromatin immunoprecipitation, co-immunoprecipitation and transient/stable transfection, at the molecular and functional levels.
Results
Expression levels of MTA1 were significantly induced in HPV-positive CCa cells. Transduction experiments showed that the E6 oncoprotein alone was sufficient to cause MTA1 upregulation. Moreover, MTA1 knockdown potentiated CDDP sensitivity in highly metastatic CCa cells. Mechanistically, MTA1 acted as an indirect upstream modulator of APOBEC3B transcription during the pathogenesis of CDDP chemoresistance. HPV-mediated stimulation of APOBEC3B expression was accompanied by the enhanced recruitment of Iκκ α/β and p65 to the NF-κB consensus sites in the
APOBEC3B
promoter, and this recruitment was substantially abrogated by MTA1 siRNA treatment.
Conclusions
These findings reveal an obligatory coregulatory role of MTA1 in the indirect regulation of APOBEC3B expression via classical NF-κB pathway, and also suggest that inhibition of MTA1/NF-κB/APOBEC3B cascade may be repositioned to suppress cancer mutagenesis, dampen tumor evolution, and decrease the probability of adverse outcomes from CDDP resistance in CCa.</description><subject>Animals</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis</subject><subject>Cancer</subject><subject>Cancer Research</subject><subject>Carcinogenesis</subject><subject>Carcinogens</subject><subject>Cervical cancer</subject><subject>Cervix</subject><subject>Chemoresistance</subject><subject>Chemotherapy</subject><subject>Chromatin</subject><subject>Cisplatin</subject><subject>Cisplatin - pharmacology</subject><subject>Cytidine Deaminase - metabolism</subject><subject>Cytosine</subject><subject>Cytosine deaminase</subject><subject>Deoxyribonucleic acid</subject><subject>Deregulation</subject><subject>DNA</subject><subject>DNA-Binding Proteins - metabolism</subject><subject>Etiology</subject><subject>Female</subject><subject>Gene regulation</subject><subject>Human papillomavirus</subject><subject>Humans</subject><subject>Immunoblotting</subject><subject>Immunoprecipitation</subject><subject>In vivo methods and tests</subject><subject>Lesions</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Nude</subject><subject>Minor Histocompatibility Antigens - metabolism</subject><subject>Mutagenesis</subject><subject>NF-kappa B - metabolism</subject><subject>NF-κB protein</subject><subject>Oncogene Proteins, Viral - metabolism</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Papillomaviridae</subject><subject>Papillomavirus Infections - complications</subject><subject>Pathogenesis</subject><subject>Pharmacology/Toxicology</subject><subject>Polymerase chain reaction</subject><subject>Proteins</subject><subject>Repressor Proteins - genetics</subject><subject>siRNA</subject><subject>Trans-Activators - genetics</subject><subject>Transcription</subject><subject>Transfection</subject><subject>Up-Regulation</subject><subject>Uterine Cervical Neoplasms - drug therapy</subject><subject>Uterine Cervical Neoplasms - virology</subject><subject>Xenograft Model Antitumor Assays</subject><issn>0344-5704</issn><issn>1432-0843</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kUtOHDEURa0oUegAG2CALGXs8Pwpl2vY3UASiQADGFsu1ysoVD_srlZYTDaSRWRNcdP8RowsP597r54vIQccvnGA_CgCCAMMuGEgc62Z-EBmXEnBwCj5kcxAKsWyHNQO-RLjHQAoLuVnsiNBS24KMyN_rseAN1PrVs3Q06Gmv67mnOLvNI1xMyof6O3UuZ6ObmzadujcuglTpE1fo38UjWHohhVGujw-vqRJ18SV6z0mhHoM68a7lvrNJKR720a6bhzthupN6vkp-_d3cTS_vFicLOUi4dG7CvfIp9q1Efefzl1yfXpytfzBzi6-_1zOz5gXBQgmpSwqRF1UZYF5XelMudJxU2shvUFfAgqZc48GdF0JU9aGi9yVmU_fqJSSu-Tr1jftcj9hXNm7YQp9irSC66zQKSZLlNhSPgwxBqztGJrOhQfLwW4asdtGbGrEPjZiRRIdPllPZYfVi-S5ggTILRDTU3-D4TX7Hdv_r1OYaA</recordid><startdate>201904</startdate><enddate>201904</enddate><creator>Jia, Qiu-ping</creator><creator>Yan, Chang-you</creator><creator>Zheng, Xue-rong</creator><creator>Pan, Xia</creator><creator>Cao, Xin</creator><creator>Cao, Lei</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>201904</creationdate><title>Upregulation of MTA1 expression by human papillomavirus infection promotes CDDP resistance in cervical cancer cells via modulation of NF-κB/APOBEC3B cascade</title><author>Jia, Qiu-ping ; Yan, Chang-you ; Zheng, Xue-rong ; Pan, Xia ; Cao, Xin ; Cao, Lei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2902-3339dee69db9e7fd654aba18f623c8ecb0e2371ce806fd28bf8127ab5c0074443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis</topic><topic>Cancer</topic><topic>Cancer Research</topic><topic>Carcinogenesis</topic><topic>Carcinogens</topic><topic>Cervical cancer</topic><topic>Cervix</topic><topic>Chemoresistance</topic><topic>Chemotherapy</topic><topic>Chromatin</topic><topic>Cisplatin</topic><topic>Cisplatin - pharmacology</topic><topic>Cytidine Deaminase - metabolism</topic><topic>Cytosine</topic><topic>Cytosine deaminase</topic><topic>Deoxyribonucleic acid</topic><topic>Deregulation</topic><topic>DNA</topic><topic>DNA-Binding Proteins - metabolism</topic><topic>Etiology</topic><topic>Female</topic><topic>Gene regulation</topic><topic>Human papillomavirus</topic><topic>Humans</topic><topic>Immunoblotting</topic><topic>Immunoprecipitation</topic><topic>In vivo methods and tests</topic><topic>Lesions</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Nude</topic><topic>Minor Histocompatibility Antigens - metabolism</topic><topic>Mutagenesis</topic><topic>NF-kappa B - metabolism</topic><topic>NF-κB protein</topic><topic>Oncogene Proteins, Viral - metabolism</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Papillomaviridae</topic><topic>Papillomavirus Infections - complications</topic><topic>Pathogenesis</topic><topic>Pharmacology/Toxicology</topic><topic>Polymerase chain reaction</topic><topic>Proteins</topic><topic>Repressor Proteins - genetics</topic><topic>siRNA</topic><topic>Trans-Activators - genetics</topic><topic>Transcription</topic><topic>Transfection</topic><topic>Up-Regulation</topic><topic>Uterine Cervical Neoplasms - drug therapy</topic><topic>Uterine Cervical Neoplasms - virology</topic><topic>Xenograft Model Antitumor Assays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jia, Qiu-ping</creatorcontrib><creatorcontrib>Yan, Chang-you</creatorcontrib><creatorcontrib>Zheng, Xue-rong</creatorcontrib><creatorcontrib>Pan, Xia</creatorcontrib><creatorcontrib>Cao, Xin</creatorcontrib><creatorcontrib>Cao, Lei</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Cancer chemotherapy and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jia, Qiu-ping</au><au>Yan, Chang-you</au><au>Zheng, Xue-rong</au><au>Pan, Xia</au><au>Cao, Xin</au><au>Cao, Lei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Upregulation of MTA1 expression by human papillomavirus infection promotes CDDP resistance in cervical cancer cells via modulation of NF-κB/APOBEC3B cascade</atitle><jtitle>Cancer chemotherapy and pharmacology</jtitle><stitle>Cancer Chemother Pharmacol</stitle><addtitle>Cancer Chemother Pharmacol</addtitle><date>2019-04</date><risdate>2019</risdate><volume>83</volume><issue>4</issue><spage>625</spage><epage>637</epage><pages>625-637</pages><issn>0344-5704</issn><eissn>1432-0843</eissn><abstract>Objective
Compelling evidence establishes the etiological role of viral proteins E6 and E7 of high-risk human papillomaviruses (HPV) in cervical carcinogenesis, but their contribution in chemoresistance that leads to advanced metastatic lesions remains poorly defined. Since metastasis-associated protein 1 (MTA1) upregulation and augmentation of APOBEC3B expression are both strongly associated with cervical cancer (CCa) development, and both molecules have been shown to be functionally associated with NF-κB pathway, we therefore sought to investigate the potential mechanistic link between MTA1, APOBEC3B and NF-κB during the pathogenesis of cisplatin (CDDP) resistance in HPV-positive CCa cells.
Methods
MTA1 expression was assessed in HPV-transfected CCa cells using quantitative RT-PCR and immunoblotting. Effects of MTA1 deregulation on CDDP chemosensitivity in CCa cells were determined by measuring cell viability, apoptosis and in vivo oncogenic capacity. Finally, we studied the transcriptional regulation of the antiviral DNA cytosine deaminase APOBEC3B by MTA1 using multiple approaches including DNA deaminase activity assay, luciferase reporter assay, chromatin immunoprecipitation, co-immunoprecipitation and transient/stable transfection, at the molecular and functional levels.
Results
Expression levels of MTA1 were significantly induced in HPV-positive CCa cells. Transduction experiments showed that the E6 oncoprotein alone was sufficient to cause MTA1 upregulation. Moreover, MTA1 knockdown potentiated CDDP sensitivity in highly metastatic CCa cells. Mechanistically, MTA1 acted as an indirect upstream modulator of APOBEC3B transcription during the pathogenesis of CDDP chemoresistance. HPV-mediated stimulation of APOBEC3B expression was accompanied by the enhanced recruitment of Iκκ α/β and p65 to the NF-κB consensus sites in the
APOBEC3B
promoter, and this recruitment was substantially abrogated by MTA1 siRNA treatment.
Conclusions
These findings reveal an obligatory coregulatory role of MTA1 in the indirect regulation of APOBEC3B expression via classical NF-κB pathway, and also suggest that inhibition of MTA1/NF-κB/APOBEC3B cascade may be repositioned to suppress cancer mutagenesis, dampen tumor evolution, and decrease the probability of adverse outcomes from CDDP resistance in CCa.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>30631898</pmid><doi>10.1007/s00280-018-03766-2</doi><tpages>13</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0344-5704 |
ispartof | Cancer chemotherapy and pharmacology, 2019-04, Vol.83 (4), p.625-637 |
issn | 0344-5704 1432-0843 |
language | eng |
recordid | cdi_proquest_journals_2165962905 |
source | MEDLINE; Springer Nature - Complete Springer Journals |
subjects | Animals Antineoplastic Agents - pharmacology Apoptosis Cancer Cancer Research Carcinogenesis Carcinogens Cervical cancer Cervix Chemoresistance Chemotherapy Chromatin Cisplatin Cisplatin - pharmacology Cytidine Deaminase - metabolism Cytosine Cytosine deaminase Deoxyribonucleic acid Deregulation DNA DNA-Binding Proteins - metabolism Etiology Female Gene regulation Human papillomavirus Humans Immunoblotting Immunoprecipitation In vivo methods and tests Lesions Medicine Medicine & Public Health Metastases Metastasis Mice, Inbred BALB C Mice, Nude Minor Histocompatibility Antigens - metabolism Mutagenesis NF-kappa B - metabolism NF-κB protein Oncogene Proteins, Viral - metabolism Oncology Original Article Papillomaviridae Papillomavirus Infections - complications Pathogenesis Pharmacology/Toxicology Polymerase chain reaction Proteins Repressor Proteins - genetics siRNA Trans-Activators - genetics Transcription Transfection Up-Regulation Uterine Cervical Neoplasms - drug therapy Uterine Cervical Neoplasms - virology Xenograft Model Antitumor Assays |
title | Upregulation of MTA1 expression by human papillomavirus infection promotes CDDP resistance in cervical cancer cells via modulation of NF-κB/APOBEC3B cascade |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T00%3A37%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Upregulation%20of%20MTA1%20expression%20by%20human%20papillomavirus%20infection%20promotes%20CDDP%20resistance%20in%20cervical%20cancer%20cells%20via%20modulation%20of%20NF-%CE%BAB/APOBEC3B%20cascade&rft.jtitle=Cancer%20chemotherapy%20and%20pharmacology&rft.au=Jia,%20Qiu-ping&rft.date=2019-04&rft.volume=83&rft.issue=4&rft.spage=625&rft.epage=637&rft.pages=625-637&rft.issn=0344-5704&rft.eissn=1432-0843&rft_id=info:doi/10.1007/s00280-018-03766-2&rft_dat=%3Cproquest_cross%3E2165962905%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2165962905&rft_id=info:pmid/30631898&rfr_iscdi=true |